Amgen Cancer Drug Kyprolis Failure Is Not the End of the Road - - TopicsExpress



          

Amgen Cancer Drug Kyprolis Failure Is Not the End of the Road - Diabetes Insider Amgen Cancer Drug Kyprolis Failure Is Not the End of the RoadDiabetes InsiderWhile early clinical trials of Amgens new cancer drug all passed without incident, Kyprolis failed a trial today. That could mean more than just returning to the drawing board. All that matters when it comes to cancer treatments is how long a patient can live with ...Amgen Blood Cancer Drug Fails Primary Endpoint In Late-Stage StudyAmgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg ...Amgen drug fails to improve survival in multiple myeloma trial
Posted on: Thu, 14 Aug 2014 10:29:40 +0000

Trending Topics



Recently Viewed Topics




© 2015